Is there a place for serum laminin determination in patients with liver disease and cancer?

World Journal of Gastroenterology

Volumn 14, Issue 23, 2008, Pages 3628-3632

  Rosa, Heitor ^a   Parise, Edison Roberto ^b  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cancer; Cirrhosis; Fibrosis markers; Hepatic fibrosis; Laminin

Indexed keywords

ALPHA FETOPROTEIN; COLLAGEN TYPE 4; HYALURONIC ACID; LAMININ; TUMOR MARKER;

CANCER INVASION; CARCINOMATOUS PERITONITIS; CELL PROLIFERATION; DIAGNOSTIC ACCURACY; EPITHELIUM TUMOR; FATTY LIVER; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER CANCER; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FIBROSIS; METASTASIS; NON INVASIVE PROCEDURE; NONALCOHOLIC FATTY LIVER; PORTAL HYPERTENSION; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SPLENECTOMY;

EID: 54349102331     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.3628     Document Type: Review

References (57)

1. Timpl R, Rohde H, Robey PG, Rennard SI, Foidart JM, Martin GR. Laminin - a glycoprotein from basement membranes. J Biol Chem 1979; 254: 9933-9937
2. Burgeson RE, Chiquet M, Deutzmann R, Ekblom P, Engel J, Kleinman H, Martin GR, Meneguzzi G, Paulsson M, Sanes J. A new nomenclature for the laminins. Matrix Biol 1994; 14: 209-211
3. Aumailley M, Smyth N. The role of laminins in basement membrane function. J Anat 1998; 193 (Pt 1): 1-21
4. Kleinman HK, Cannon FB, Laurie GW, Hassell JR, Aumailley M, Terranova VP, Martin GR, DuBois-Dalcq M. Biological activities of laminin. J Cell Biochem 1985; 27: 317-325
5. Kershenobich Stalnikowitz D, Weissbrod AB. Liver fibrosis and inflammation. A review. Ann Hepatol 2003; 2: 159-163
6. Mecham RP. Receptors for laminin on mammalian cells. FASEB J 1991; 5: 2538-2546
7. Haas TA, Plow EF. Integrin-ligand interactions: a year in review. Curr Opin Cell Biol 1994; 6: 656-662
8. Valkonen KH, Ringner M, Ljungh A, Wadstrom T. High-affinity binding of laminin by Helicobacter pylori: evidence for a lectin-like interaction. FEMS Immunol Med Microbiol 1993; 7: 29-37
9. Martinez-Hernandez A. The hepatic extracellular matrix. I. Electron immunohistochemical studies in normal rat liver. Lab Invest 1984; 51: 57-74
10. Parise ER, Summerfield JA, Hahn E, Wiedmann KH, Doenhoff MJ. Basement membrane proteins and type III procollagen in murine schistosomiasis. Trans R Soc Trop Med Hyg 1985; 79: 663-670
11. Shah KD, Gerber MA. Development of intrahepatic bile ducts in humans. Possible role of laminin. Arch Pathol Lab Med 1990; 114: 597-600
12. Caron JM. Induction of albumin gene transcription in hepatocytes by extracellular matrix proteins. Mol Cell Biol 1990; 10: 1239-1243
13. Martinez-Hernandez A, Delgado FM, Amenta PS. The extracellular matrix in hepatic regeneration. Localization of collagen types I, III, IV, laminin, and fibronectin. Lab Invest 1991; 64: 157-166
14. Voss B, Rauterberg J. Investigation on the biosynthesis of connective tissue components by cultured mouse liver macrophages and mouse peritoneal macrophages. In: Sinusoidal liver cells. Amsterdam: Elsevier, 1982; 201-208
15. Gressner AM, Bachem MG. Cellular sources of noncollagenous matrix proteins: role of fat-storing cells in fibrogenesis. Semin Liver Dis 1990; 10: 30-46
16. Schaffner F, Popper H. Capillarization of hepatic sinusoids in man. Gastroenterology 1963; 44: 239-242
17. Smedsrod B, Paulsson M, Johansson S. Uptake and degradation in vivo and in vitro of laminin and nidogen by rat liver cells. Biochem J 1989; 261: 37-42
18. Hahn E, Wick G, Pencev D, Timpl R. Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV, laminin, and fibronectin. Gut 1980; 21: 63-71
19. Schneider M, Voss B, Hogemann B, Eberhardt G, Gerlach U. Evaluation of serum laminin P1, procollagen-III peptides, and N-acetyl-beta-glucosaminidase for monitoring the activity of liver fibrosis. Hepatogastroenterology 1989; 36: 506-510
20. Niemela O, Risteli J, Blake JE, Risteli L, Compton KV, Orrego H. Markers of fibrogenesis and basement membrane formation in alcoholic liver disease. Relation to severity, presence of hepatitis, and alcohol intake. Gastroenterology 1990; 98: 1612-1619
21. Korner T, Kropf J, Gressner AM. Serum laminin and hyaluronan in liver cirrhosis: markers of progression with high prognostic value. J Hepatol 1996; 25: 684-688
22. Kropf J, Gressner AM, Tittor W. Logistic-regression model for assessing portal hypertension by measuring hyaluronic acid (hyaluronan) and laminin in serum. Clin Chem 1991; 37: 30-35
23. Annoni G, Colombo M, Cantaluppi MC, Khlat B, Lampertico P, Rojkind M. Serum type III procollagen peptide and laminin (Lam-P1) detect alcoholic hepatitis in chronic alcohol abusers. Hepatology 1989; 9: 693-697
24. Gressner AM, Tittor W. Serum laminin - its concentration increases with portal hypertension in cirrhotic liver disease. Klin Wochenschr 1986; 64: 1240-1248
25. Mal F, Hartmann DJ, Trinchet JC, Lacombe F, Ville G, Beaugrand M. [Serum laminin and portal pressure in alcoholic cirrhosis. A study of 39 patients] Gastroenterol Clin Biol 1988; 12: 841-844
26. Kondo M, Miszputen SJ, Leite-mor MM, Parise ER. The predictive value of serum laminin for the risk of variceal bleeding related to portal pressure levels. Hepatogastroenterology 1995; 42: 542-545
27. Gressner AM, Tittor W, Negwer A. Serum concentrations of N-terminal propeptide of type III procollagen and laminin in the outflow of fibrotic livers compared with liver-distal regions. Hepatogastroenterology 1986; 33: 191-195
28. Neves LB, Catarino RM, Silva MR, Parise ER. [Increased serum levels of laminin in the experimental cirrhosis induced by carbon tetrachloride] Arq Gastroenterol 2003; 40: 173-176
29. Neves LB. Estudo da laminina sérica e de sua deposição no fígado de ratos com fibrose hepática induzida pelo tetracloreto de carbono. Thesis UNIFESP, 2000
30. Parise ER, Rosa H. Serum laminin in hepatic schistosomiasis. Trans R Soc Trop Med Hyg 1992; 86: 179-181
31. Parise ER, Leite-Mor MM, Rosa H. Serum laminin in hepatosplenic human schistosomiasis. Mem Inst Oswaldo Cruz 1992; 87 Suppl 4: 127-128
32. Grimaud JA, Borojevic R. Chronic human schistosomiasis mansoni. Pathology of the Disse's space. Lab Invest 1977; 36: 268-273
33. Wyszomirska RMAF. Determinação sérica dos marcadores de fibrose hepática em portadores de esquistossomose mansânica: avaliação do colágeno tipo IV e laminina. Thesis. 1999 University of Campinas 1999. Sao Paulo, 118: 1117-1123
34. Borojevic R, Grimaud JA. Collagen fibers in enlarged basement membranes in human schistosomal liver and spleen. Cell Mol Biol Incl Cyto Enzymol 1980; 26: 247-250
35. Li ZX, He Y, Wu J, Liang DM, Zhang BL, Yang H, Wang LL, Ma Y, Wei KL. Noninvasive evaluation of hepatic fibrosis in children with infant hepatitis syndrome. World J Gastroenterol 2006; 12: 7155-7160
36. Lydatakis H, Hager IP, Kostadelou E, Mpousmpoulas S, Pappas S, Diamantis I. Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease. Liver Int 2006; 26: 864-871
37. Lebensztejn DM, Skiba E, Sobaniec-Lotowska ME, Kaczmarski M. Serum hyaluronan and laminin level in children with chronic hepatitis B during long-term lamivudine treatment. Hepatogastroenterology 2007; 54: 834-838
38. Sakugawa H, Nakayoshi T, Kobashigawa K, Yamashiro T, Maeshiro T, Miyagi S, Shiroma J, Toyama A, Nakayoshi T, Kinjo F, Saito A. Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease. World J Gastroenterol 2005; 11: 255-259
39. Attallah AM, Toson EA, Shiha GE, Omran MM, Abdel-Aziz MM, El-Dosoky I. Evaluation of serum procollagen aminoterminal propeptide III, laminin, and hydroxyproline as predictors of severe fibrosis in patients with chronic hepatitis C. J Immunoassay Immunochem 2007; 28: 199-211
40. Katayama M, Funakoshi A, Sumii T, Sanzen N, Sekiguchi K. Laminin gamma2-chain fragment circulating level increases in patients with metastatic pancreatic ductal cell adenocarcinomas. Cancer Lett 2005; 225: 167-176
41. Gressner OA, Weiskirchen R, Gressner AM. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests. Clin Chim Acta 2007; 381: 107-113
42. Santos VN, Leite-Mor MM, Kondo M, Martins JR, Nader H, Lanzoni VP, Parise ER. Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease. Braz J Med Biol Res 2005; 38: 747-753
43. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-1419
44. Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, Khalil L, Turpin G, Opolon P, Poynard T. Liver fibrosis in overweight patients. Gastroenterology 2000; 118: 1117-1123
45. Liotta LA, Rao CN, Wewer UM. Biochemical interactions of tumor cells with the basement membrane. Annu Rev Biochem 1986; 55: 1037-1057
46. AbouFarha KM, Menheere PP, Nieman FH, Arends JW, Janknegt RA. Value of serum laminin P1 as a diagnostic and monitoring parameter in transitional cell carcinoma of the bladder. Urol Int 1992; 49: 130-136
47. Nakano T, Iwahashi N, Maeda J, Hada T, Higashino K. Serum laminin P1 in small cell lung cancer: a valuable indicator of distant metastasis? Br J Cancer 1992; 65: 608-612
48. Rochlitz C, Hasslacher C, Brocks DG, Herrmann R. Serum concentration of laminin, and course of the disease in patients with various malignancies. J Clin Oncol 1987; 5: 1424-1429
49. Saito N, Kameoka S. Serum laminin is an independent prognostic factor in colorectal cancer. Int J Colorectal Dis 2005; 20: 238-244
50. Gao ZL, Zhang C, Du GY, Lu ZJ. Clinical significance of changes in tumor markers, extracellular matrix, MMP-9 and VEGF in patients with gastric carcinoma. Hepatogastroenterology 2007; 54: 1591-1595
51. Qin LX, Tang ZY. Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature. J Cancer Res Clin Oncol 2004; 130: 497-513
52. Burchardt ER, Hein R, Bosserhoff AK. Laminin, hyaluronan, tenascin-C and type VI collagen levels in sera from patients with malignant melanoma. Clin Exp Dermatol 2003; 28: 515-520
53. Byers LJ, Osborne JL, Carson LF, Carter JR, Haney AF, Weinberg JB, Ramakrishnan S. Increased levels of laminin in ascitic fluid of patients with ovarian cancer. Cancer Lett 1995; 88: 67-72
54. Chu Y, Yang Y, Lin M, Wang Z. Detection of laminin in serum and ascites from patients with epithelial ovarian tumor. J Huazhong Univ Sci Technolog Med Sci 2002; 22: 58-59, 68
55. Catarino RM, Lopes JD, Forones NM, Parise ER. Laminin concentration in ascites of patients with hepatic cirrhosis and peritoneal carcinomatosis. Braz J Med Biol Res 2005; 38: 271-276
56. Su Q, Fu Y, Liu YF, Zhang W, Liu J, Wang CM. Laminin induces the expression of cytokeratin 19 in hepatocellular carcinoma cells growing in culture. World J Gastroenterol 2003; 9: 921-929
57. Yoshida K, Tadaoka Y, Manabe T. Expression of laminin in hepatocellular carcinoma: an adjunct for its histological diagnosis. Jpn J Clin Oncol 1996; 26: 70-76